New York Cancer and Blood Specialists

Riverhead, NY

Sorting 1 by

Not yet accepting

QXL138AM

A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally Advanced Un-resectable and/or Metastatic Solid Tumors and Multiple Myeloma
  • Masked Immunocytokine (MIC)
  • CD138
  • Phase 1